Molecular links between obesity and breast cancer

被引:331
作者
Lorincz, A. M.
Sukumar, S.
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Breast Canc Program, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Grad Program Pathobiol, Baltimore, MD 21231 USA
关键词
D O I
10.1677/erc.1.00729
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer continues to be a major health problem for women in the USA and worldwide. There is a need to identify and take steps to alter modifiable breast cancer risks. Conditions of obesity and overweight are risk factors that have reached epidemic proportions. This article reviews the evidence in the literature that test mechanism-based hypotheses which attempt to provide a molecular basis for a causal link between obesity and breast cancer risk, particularly the effects of metabolic syndrome and insulin resistance, peripheral estrogen aromatization in adipose tissue, and direct effect of adipokines. Future areas for study and implications for therapy are discussed.
引用
收藏
页码:279 / 292
页数:14
相关论文
共 111 条
[1]   Role of leptin in the neuroendocrine response to fasting [J].
Ahima, RS ;
Prabakaran, D ;
Mantzoros, C ;
Qu, DQ ;
Lowell, B ;
MaratosFlier, E ;
Flier, JS .
NATURE, 1996, 382 (6588) :250-252
[2]   Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women [J].
Allen, NE ;
Appleby, PN ;
Kaaks, R ;
Rinaldi, S ;
Davey, GK ;
Key, TJ .
CANCER CAUSES & CONTROL, 2003, 14 (01) :65-74
[3]   Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Maeda, K ;
Kuriyama, H ;
Okamoto, Y ;
Kumada, M ;
Hotta, K ;
Nishida, M ;
Takahashi, M ;
Nakamura, T ;
Shimomura, I ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
CIRCULATION, 2002, 105 (24) :2893-2898
[4]   Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients [J].
Bachelot, T ;
Ray-Coquard, I ;
Menetrier-Caux, C ;
Rastkha, M ;
Duc, A ;
Blay, JY .
BRITISH JOURNAL OF CANCER, 2003, 88 (11) :1721-1726
[5]  
BALLARDBARBASH R, 1990, CANCER RES, V50, P2152
[6]   Body mass index as a prognostic feature in operable breast cancer:: the International Breast Cancer Study Group experience [J].
Berclaz, G ;
Li, S ;
Price, KN ;
Coates, AS ;
Castiglione-Gertsch, M ;
Rudenstam, CM ;
Holmberg, SB ;
Lindtner, J ;
Erzen, D ;
Collins, J ;
Snyder, R ;
Thürlimann, B ;
Fey, MF ;
Mendiola, C ;
Werner, ID ;
Simoncini, E ;
Crivellari, D ;
Gelber, RD ;
Goldhirsch, A ;
International Breast Cancer Study Grp .
ANNALS OF ONCOLOGY, 2004, 15 (06) :875-884
[7]   Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis [J].
Bråkenhielm, E ;
Veitonmäki, N ;
Cao, RH ;
Kihara, S ;
Matsuzawa, YJ ;
Zhivotovsky, B ;
Funahashi, T ;
Cao, YH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (08) :2476-2481
[8]  
Brinton L A, 1992, Ann Epidemiol, V2, P597, DOI 10.1016/1047-2797(92)90004-A
[9]   Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression [J].
Bulló, M ;
García-Lorda, P ;
Megias, I ;
Salas-Salvadó, J .
OBESITY RESEARCH, 2003, 11 (04) :525-531
[10]   AROMATASE GENE-EXPRESSION IN ADIPOSE-TISSUE - RELATIONSHIP TO BREAST-CANCER [J].
BULUN, SE ;
MAHENDROO, MS ;
SIMPSON, ER .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 49 (4-6) :319-326